NovaQuest Pharma Opportunities Fund IV (Co-Invest), L.P. — Form D
NovaQuest Pharma Opportunities Fund IV (Co-Invest), L.P. of RALEIGH, NC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2015-12-28. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2015-12-28
- Form: D
- Accession: 0001655103-15-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $75.0M
- Amount sold: $75.0M
- Minimum investment: $75.0M
- Investors: 1
- Date of first sale: 2015-12-18
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-253893
Issuer
- Name: NovaQuest Pharma Opportunities Fund IV (Co-Invest), L.P.
- CIK: 0001655103
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2015
- Address: 4208 SIX FORKS ROAD, RALEIGH, NC, 27609
- Phone: 919-459-8620
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| JOHN L BRADLEY | Director | RALEIGH, NC |
| Ernest Gerald Brown | Director | Raleigh, NC |
| Mitsuhiro Gerald Goto | Director | Raleigh, NC |
| Ronald Gerald Wooten | Director | Raleigh, NC |
| N/A NQ POF IV GP, L.P. | Executive Officer | Raleigh, NC |
| N/A NQ POF IV GP, Ltd. | Executive Officer | Raleigh, NC |
More